Morgan Stanley Has Lowered Expectations for Maravai LifeSciences (NASDAQ:MRVI) Stock Price
Maravai LifeSciences (NASDAQ:MRVI – Get Free Report) had its price target reduced by Morgan Stanley from $7.00 to $5.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has an “equal weight” rating on the stock. Morgan Stanley’s target price suggests a potential upside of 110.97% from the company’s previous close. Several other […]
Maravai LifeSciences (NASDAQ:MRVI – Get Free Report) had its price target reduced by Morgan Stanley from $7.00 to $5.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has an “equal weight” rating on the stock. Morgan Stanley’s target price suggests a potential upside of 110.97% from the company’s previous close. Several other […]
